Adaptive clinical trials use algorithms to predict, during the study, patient outcomes and final study results. These predictions trigger interim decisions, such as early discontinuation of the trial, ...
Performance meets or exceeds targets for identifying Rapid Kidney Function Decline in patients with Type 2 diabetes and existing chronic kidney disease Initial performance targets, as outlined in a ...
NEW YORK, July 9, 2019 /PRNewswire/ -- Renalytix AI plc (AIM: RENX), a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, announced today positive interim analysis ...
Adjuvant Therapy for Renal Cell Carcinoma: End Points, Outcomes, and Risk Assessments Adaptive clinical trials use algorithms to predict, during the study, patient outcomes and final study results.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback